Vitamin B₁₂-loaded solid lipid nanoparticles as a drug carrier in cancer therapy

References

• Rao DP, Srivastav SK, Prasad C, et al. Role of nanoparticles in drug delivery. Int J Nanotechnol Appl 2010;4:45–49
   Google Scholar
• Orive G, Hernandez RM, Gascon AR, Pedraz JL. Micro and nano drug delivery systems in cancer therapy. Cancer Ther 2005;3:131–138
   Google Scholar
• Vasir JK, Reddy MK, Labhasetwar VD. Nanosytems in drug targeting: opportunities and challenges. Curr Nanosci 2005;1:47–64
   Web of Science ®Google Scholar
• Hughes GA. Nanostructure-mediated drug delivery. Nanomed Nanotechnol Biol Med 2005;1:22–30
   PubMed Web of Science ®Google Scholar
• Dingler A, Blum RP, Nıehus H, et al. Solid lipid nanoparticle (SLNTM/LipopearlsTM) a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products. J Microencapsul 1999;16:751–767
   PubMed Web of Science ®Google Scholar
• Bose JC, Duraisami K, Surrendiren NS. Review on nanoparticle based therapeutics and drug delivery system. Asian J Pharm 2011;2:139–140
   Google Scholar
• Jores K, Mehnert W, Bunjes H, et al. Controlled Release Society 30th Annual Meeting Proceedings; 2003
   Google Scholar
• Mukherjee S, Ray S, Thakur S. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci 2009;71:349–357
   PubMed Web of Science ®Google Scholar
• Kamble VA, Jagdale DM, Kadam VJ. Solid lipid nanoparticles as drug delivery system. Int J Pharm Biol Sci 2010;1:1–9
   Google Scholar
• Raval G, Sainger R, Rawal MR, et al. Vitamin B12 and folate status in head and neck cancer. Asian Pac J Cancer Prev 2002;3:155–162
   PubMedGoogle Scholar
• Obeid R, Kuhlmann M, Kirsch CM, Herrman W. Cellular uptake of vitamin B12 in patients with chronic renal failure. Nephron Clin Pract 2005;99:44–48
   Google Scholar
• Coelho D, Suormala T, Stucki M, et al. Gene identification for the cblD defect of vitamin B12 metabolism. N Engl J Med 2008;358:1454–1464
   PubMed Web of Science ®Google Scholar
• Waibel R, Treichler H, Schaefer NG, et al. New derivatives of vitamin B12 show preferential targeting of tumors. Cancer Res 2008;68:2904–2911
   PubMed Web of Science ®Google Scholar
• Zhang SM, Willett WC, Selhub J, et al. Plasma folate, vitamin B6, vitamin B12, homocysteine and risk of breast cancer. J Natl Cancer Inst 2003;95:373–380
   PubMedGoogle Scholar
• Lin J, Lee I, Cook NR, et al. Plasma folate, vitamin B6, vitamin B12 and risk of breast cancer in women. Am J Clin Nutr 2008;87:734–743
   PubMed Web of Science ®Google Scholar
• Byström P, Björkegren K, Larsson A, et al. Serum vitamin B12 and folate status among patients with chemotherapy treatment for advanced colorectal cancer. Upsala J Med Sci 2009;114:160–164
   PubMed Web of Science ®Google Scholar
• Muller RH, Lucks JS. Arzneistofftrager aus festen Lipidteilchen, Feste Lipidnanospharen (SLN). European Patent EP0605497; 1996
   Google Scholar
• Scalia S, Mezzana M. Incorporation in lipid microparticles of the UVA filter, butyl methoxydibenzoylmethane combined with the UVB filter, octoxrylene: effect on photostability. AAPS Pharm Sci Technol 2009;10:384–390
   PubMed Web of Science ®Google Scholar
• Nagarwal RC, Kant S, Singh PN, et al. Polymeric nanoparticulate systems: a potential approach for ocular drug delivery. J Controll Rel 2009;136:2--13
   PubMed Web of Science ®Google Scholar
• ICH Topic Q2B. Validation of analytical procedures: methodology. The European Agency for the evaluation of medicinal products. CPMP/ICH/281/95, Step 4, Consensus Guideline; 1996
   Google Scholar
• Fotokis G, Timbrell A. In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. J Toxicol Lett 2006;160:171–177
   PubMed Web of Science ®Google Scholar
• Andrea G. Use of antioxidants during chemotherapy and radiotherapy should be avoided. Cancer J Clin 2005;55:319–321
   PubMed Web of Science ®Google Scholar
• Fenech MF, Dreosti IE, Rinaldi JR. Folate, vitamin B12, homocysteine status and chromosome damage rate in lymphocytes of older men. Carcinogenesis 1997;18:1329–1336
   PubMed Web of Science ®Google Scholar
• Lajous M, Romieu I, Sabia S, et al. Folate, vitamin B12 and postmenopausal breast cancer in a prospective study of French women. Cancer Causes Control 2006;17:1209–1213
   PubMed Web of Science ®Google Scholar
• Alberg AJ, Selhub J, Shah KV, et al. The risk of cervical cancer in relation serum concentration of folate, vitamin B12 and homocysteine. Cancer Epidemiol 2000;9:761–764
   PubMed Web of Science ®Google Scholar
• Matthews JH. The cytotoxic effect of the vitamin B12 inhibitor cyanocobalamin (c-lactam) and a review of other vitamin B12 antagonist. Leuk Lymphoma 2010;31:21–37
   Google Scholar
• Schernhammer E, Wolpin B, Rifai N, et al. Plasma folate, vitamin B6, vitamin B12 and homocysteine and pancreatic cancer risk in four large cohorts. Cancer Res 2007;67:5563–5560
   Web of Science ®Google Scholar
• Otani T, Iwasaki M, Hanaoka T, et al. Folate, vitamin B6, vitamin B12 and vitamin B2 intake, genetic polymorphisms of related enzymes, and risk of colorectal cancer in a hospital-based case-control study in Japan. Nutr Cancer 2010;53:42–50
   Google Scholar
• Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery -- a review of the state of the art. Eur J Pharm Biopharm 2000;50:161–177
   PubMed Web of Science ®Google Scholar
• Souto EB, Wissing SA, Barbosa CM, Muller RH. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm 2004;278:71–77
   PubMed Web of Science ®Google Scholar
• Wissing SA, Kayser O, Muller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 2004;56:1257–1272
   PubMed Web of Science ®Google Scholar
• Souto EB, Muller RH. SLN and NLC for topical delivery of ketoconazole. J Microencapsul 2005;22:501–510
   PubMed Web of Science ®Google Scholar
• Radtke M, Souto BE, Müller RH. NLC® – the novel generation of solid lipid carriers. Pharm Tech Eur 2005;17:45–50
   Google Scholar
• Muller RH, Mehnert W, Souto EB. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for dermal delivery. New York: Marcel Dekker, Inc; 2005:719–738
   Google Scholar
• Esposito E, Fantin M, Marti M, et al. Solid lipid nanoparticles as delivery systems for bromocriptine. Pharm Res 2007;25:1521–1530
   Web of Science ®Google Scholar
• Lu B, Xiong S, Yang H, et al. Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases. Eur J Pharm Sci 2006;1403:1–10
   Google Scholar
• Alhaj NA, Abdullah R, İbrahim S, Bustamam A. Tamoxifen drug loading solid lipid nanoparticles prepared by hot high pressure homogenization techniques. Am J Pharmacol Toxicol 2008;3:219–224
   Google Scholar
• Brioschi A, Zara PG, Calderoni S, et al. Cholesterylbutyrate solid lipid nanoparticles as a butyric acid prodrug. Molecules 2008;13:230–254
   PubMed Web of Science ®Google Scholar
• Serpe L, Catalano GM, Cavalli R, et al. Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line. Eur J Pharm Biopharm 2004;58:673–680
   PubMed Web of Science ®Google Scholar
• Zhu RR, Qin LL, Wang M, et al. Preparation, characterization, and anti-tumor property of podophyllotoxin-loaded solid lipid nanoparticles. Nanotechnology 2009;20:1–7
   Web of Science ®Google Scholar
• Souto EB, Muller RH. Lipid nanoparticles (SLN and NLC) for cosmetic, dermal and transdermal applications. In: Thassu D, Deleers M, Pathak Y, Domb A, eds. Nanoparticulate drug delivery systems. Boca Raton (FL): CRC Press; 2007:213–235
   Google Scholar
• Hou D, Xie C, Huang K, Zhu C. The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials 2003;24:1781–1785
   PubMed Web of Science ®Google Scholar